Drug recall D-0136-2025
Product
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20
Reason for recall
Subpotent and Superpotent Drug
Lots and codes
Lot #: 3115869, Exp. Date 03/2025
Recall details
- Recalling firm
- Mylan Institutional, Inc., Rockford, IL
- Quantity
- 205 cartons
- Distribution
- Nationwide in the USA.
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 19, 2024
Related products
- Levothyroxine Sodium – drug information
- NDC 42292-038 Levothyroxine Sodium · Levothyroxine Sodium 88 ug/1 · Mylan Institutional Inc.
- NDC 42292-041 Levothyroxine Sodium · Levothyroxine Sodium 137 ug/1 · Mylan Institutional Inc.
- NDC 42292-040 Levothyroxine Sodium · Levothyroxine Sodium 175 ug/1 · Mylan Institutional Inc.
- NDC 42292-039 Levothyroxine Sodium · Levothyroxine Sodium 112 ug/1 · Mylan Institutional Inc.